.png)
Agenzia Italiana del Farmaco
home
COVID-19
Learn more
Highlights
-
06 Oct 2022
Monitoring Registers
Monitoring of monoclonal antibodies for COVID-19: weekly report published
AIFA publishes the results of the monitoring related to monoclonal antibodies for the treatment of COVID-19 currently available.
-
03 Oct 2022
Innovative medicinal products
Innovative medicines list: AIFA publishes September 2022 update
AIFA updates the list of medicines that, in the opinion of the Scientific and Technical Committee (CTS), meet the requirement of full or conditional therapeutic innovativeness. At the same time, the evaluation reports for the recognition of innovativeness, for each therapeutic indication, are made available.
-
23 Sep 2022
Monitoring Registers
Monitoring of antivirals for COVID-19: new report published
The Italian Medicines Agency (AIFA) has published the results of the monitoring of antivirals currently available for treating COVID-19.
-
21 Sep 2022
Biosimilar medicinal products
Statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU
EMA and the Heads of Medicines Agencies (HMA) have issued a joint statement confirming that biosimilar medicines approved in the European Union (EU) are interchangeable with their reference medicine or with an equivalent biosimilar.
News
05 Oct 2022
Consumption and pharmaceutical expenditure
Monitoring of Pharmaceutical expenditure
04 Oct 2022
Safety of medicinal products
Direct communication with healthcare professionals on Natpar (parathyroid hormone)
04 Oct 2022
Monitoring Registers
Hepatitis C: update of 3 October 2022 concerning enrolled patients
30 Sep 2022
Safety of medicinal products
New recommendations for terlipressin-containing fmedicines in the treatment of hepatorenal syndrome
30 Sep 2022
Safety of medicinal products
Highlights della riunione del Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 – 29 September
27 Sep 2022
Information and communication
Italian Medicines Agency's online services are not guaranteed due to estraordinary maintenance
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
